相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves' Ophthalmopathy-Derived Orbital Fibroblasts via RhoA-Mediated ERK and p38 Signaling Pathways
Yi-Hsuan Wei et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Antifibrotics in systemic sclerosis
Maria Martin-Lopez et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2021)
Nintedanib: A Review
Yvette N. Lamb
DRUGS (2021)
ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease
Madan Jagasia et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Novel therapies emerging in oncology to target the TGF-β pathway
Byung-Gyu Kim et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies
Hironori Adachi et al.
BIOMEDICINES (2021)
Targeting Rho-associated coiled-coil forming protein kinase (ROCK) in cardiovascular fibrosis and stiffening
Brian Yu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Targeting ROCK signaling in health, malignant and non-malignant diseases
Roya Shahbazi et al.
IMMUNOLOGY LETTERS (2020)
Non-canonical (non-SMAD2/3) TGF-β signaling in fibrosis: Mechanisms and targets
Kenneth W. Finnson et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
Identification of novel functions of the ROCK2-specific inhibitor KD025 by bioinformatics analysis
Jinjoo Park et al.
GENE (2020)
AVID200, first-in-class TGF-beta 1 and 3 selective and potent inhibitor: Safety and biomarker results of a phase I monotherapy dose-escalation study in patients with advanced solid tumors.
Timothy A Yap et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
TGF-β Signaling
Kalliopi Tzavlaki et al.
BIOMOLECULES (2020)
Synthesis and biological evaluation of 4-(pyridin-4-oxy)-3-(3,3-difluorocyclobutyl)-pyrazole derivatives as novel potent transforming growth factor-β type 1 receptor inhibitors
Guofeng Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
The myofibroblast at a glance
Pardis Pakshir et al.
JOURNAL OF CELL SCIENCE (2020)
Adipocytic Progenitor Cells Give Rise to Pathogenic Myofibroblasts: Adipocyte-to-Mesenchymal Transition and Its Emerging Role in Fibrosis in Multiple Organs
Roberta Goncalves Marangoni et al.
CURRENT RHEUMATOLOGY REPORTS (2020)
SAFETY, TARGET ENGAGEMENT, AND INITIAL EFFICACY OF AVID200, A FIRST-IN-CLASS POTENT AND ISOFORM-SELECTIVE INHIBITOR OF TGF-BETA 1 AND 3, IN PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC): A PHASE 1 DOSE ESCALATION STUDY
R. Lafyatis et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling
Warisara Parichatikanond et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Mechanical regulation of myofibroblast phenoconversion and collagen contraction
Boris Hinz et al.
EXPERIMENTAL CELL RESEARCH (2019)
Attenuation of pulmonary fibrosis in type I collagen-targeted reporter mice with ALK-5 inhibitors
Hideki Terashima et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2019)
Specificity, versatility, and control of TGF-β family signaling
Rik Derynck et al.
SCIENCE SIGNALING (2019)
ENDOTHELIAL TO MESENCHYMAL TRANSITION: ROLE IN PHYSIOLOGY AND IN THE PATHOGENESIS OF HUMAN DISEASES
Sonsoles Piera-Velazquez et al.
PHYSIOLOGICAL REVIEWS (2019)
Simvastatin and the Rho-kinase inhibitor Y-27632 prevent myofibroblast transformation in Peyronie's disease-derived fibroblasts via inhibition of YAP/TAZ nuclear translocation
Uros Milenkovic et al.
BJU INTERNATIONAL (2019)
ROCK2 regulates TGF-β-induced expression of CTGF and profibrotic genes via NF-κB and cytoskeleton dynamics in mesangial cells
Yosuke Nagai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
TGF signaling and the control of myofibroblast differentiation: Implications for chronic inflammatory disorders
Jonathon M. Carthy
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer
Silvia C. Formenti et al.
CLINICAL CANCER RESEARCH (2018)
Targeting TGF-β signaling for the treatment of fibrosis
Andrea Hermina Gyoerfi et al.
MATRIX BIOLOGY (2018)
TGF-β receptors: In and beyond TGF-β signaling
Alexandra Vander Ark et al.
CELLULAR SIGNALLING (2018)
EW-7197, an oral transforming growth factor β type I receptor kinase inhibitor, for preventing peritoneal adhesion formation in a rat model
Jiaywei Tsauo et al.
SURGERY (2018)
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
Davide Melisi et al.
BRITISH JOURNAL OF CANCER (2018)
YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer
Satoshi Noguchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Regulation of TGF-β Family Signaling by Inhibitory Smads
Keiji Miyazawa et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Novel TGF-β inhibitors ready for prime time in onco-immunology
Armand de Gramont et al.
ONCOIMMUNOLOGY (2017)
Rho kinase inhibitors: a patent review (2014-2016)
Olivier Defert et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10
Alexandra Zanin-Zhorov et al.
JOURNAL OF IMMUNOLOGY (2017)
Force interacts with macromolecular structure in activation of TGF-β
Xianchi Dong et al.
NATURE (2017)
LY3200882, a novel, highly selective TGFβRI small molecule inhibitor
Huaxing Pei et al.
CANCER RESEARCH (2017)
Phase 1b study of galunisertib in combination with gemcitabine in Japanese patients with metastatic or locally advanced pancreatic cancer
Masafumi Ikeda et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
Yangbo Feng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Revisiting the regulatory roles of the TGF-β family of cytokines
Keshi Fujio et al.
AUTOIMMUNITY REVIEWS (2016)
Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
Ryan Flynn et al.
BLOOD (2016)
The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels
Elisenda Alsina-Sanchis et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Signaling Receptors for TGF-β Family Members
Carl-Henrik Heldin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy
Hui Peng et al.
SCIENTIFIC REPORTS (2016)
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Lisa M. Rice et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis
Rhun Yian Koh et al.
MOLECULAR MEDICINE REPORTS (2015)
The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease
Svenja Hartmann et al.
FRONTIERS IN PHARMACOLOGY (2015)
First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma
Jordi Rodon et al.
CLINICAL CANCER RESEARCH (2015)
The Rho Kinases: Critical Mediators of Multiple Profibrotic Processes and Rational Targets for New Therapies for Pulmonary Fibrosis
Rachel S. Knipe et al.
PHARMACOLOGICAL REVIEWS (2015)
Rho Kinases in Health and Disease: From Basic Science to Translational Research
Gervaise Loirand
PHARMACOLOGICAL REVIEWS (2015)
Rho kinase inhibitors: a patent review (2012-2013)
Yangbo Feng et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Discovery of N-((4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of TGF-β Type I Receptor Kinase as Cancer Immunotherapeutic/Antifibrotic Agent
Cheng Hua Jin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
EW-7197, a Novel ALK-5 Kinase Inhibitor, Potently Inhibits Breast to Lung Metastasis
Ji Yeon Son et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Transforming growth factor β-at the centre of systemic sclerosis
Robert Lafyatis
NATURE REVIEWS RHEUMATOLOGY (2014)
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
John C. Morris et al.
PLOS ONE (2014)
Selective ROCK2 inhibition in focal cerebral ischemia
Jeong Hyun Lee et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Rho/Rock cross-talks with transforming growth factor-β/Smad pathway participates in lung fibroblast-myofibroblast differentiation
Hong Ji et al.
BIOMEDICAL REPORTS (2014)
LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation
Norihiko Sakai et al.
FASEB JOURNAL (2013)
Caveolin and TGF-β Entanglements
Christoph Meyer et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Role of caveolin-1 in fibrotic diseases
David Gvaramia et al.
MATRIX BIOLOGY (2013)
Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
Francesco Dituri et al.
PLOS ONE (2013)
Comparative Analysis of TGF-β/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines
Johanna Dzieran et al.
PLOS ONE (2013)
Immunological efects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients
James P. Stevenson et al.
ONCOIMMUNOLOGY (2013)
Recent Developments in Myofibroblast Biology Paradigms for Connective Tissue Remodeling
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Regulation of endothelial cell plasticity by TGF-β
Laurens A. van Meeteren et al.
CELL AND TISSUE RESEARCH (2012)
Rho-kinase regulates energy balance by targeting hypothalamic leptin receptor signaling
Hu Huang et al.
NATURE NEUROSCIENCE (2012)
The Actin-MRTF-SRF Gene Regulatory Axis and Myofibroblast Differentiation
Eric M. Small
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2012)
Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling
Damian Medici et al.
BIOCHEMICAL JOURNAL (2011)
Exploring anti-TGF-ββ therapies in cancer and fibrosis
Lukas J. A. C. Hawinkels et al.
GROWTH FACTORS (2011)
Targeted therapy for high-grade glioma with the TGF-beta 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
U. Bogdahn et al.
NEURO-ONCOLOGY (2011)
FEATURED NEW INVESTIGATOR Actin cytoskeleton in myofibroblast differentiation: Ultrastructure defining form and driving function
Nathan Sandbo et al.
TRANSLATIONAL RESEARCH (2011)
Protein kinases: evolution of dynamic regulatory proteins
Susan S. Taylor et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Stretchy Proteins on Stretchy Substrates: The Important Elements of Integrin-Mediated Rigidity Sensing
Simon W. Moore et al.
DEVELOPMENTAL CELL (2010)
Targeting the transforming growth factor-beta signaling pathway in human cancer
Nagathihalli S. Nagaraj et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Role of Growth Factors in the Pathogenesis of Tissue Fibrosis in Systemic Sclerosis
Sergio A. Jimenez et al.
CURRENT RHEUMATOLOGY REVIEWS (2010)
TGF-β and fibrosis in different organs - molecular pathway imprints
Dirk Pohlers et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Serine/Threonine Phosphatases: Mechanism through Structure
Yigong Shi
CELL (2009)
TGF-beta signaling in vascular biology and dysfunction
Marie-Jose Goumans et al.
CELL RESEARCH (2009)
FBN-1/TGF-β relationships and fibrillopathies
Julien Wipff et al.
M S-MEDECINE SCIENCES (2009)
ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes
Kenneth W. Finnson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Role of TGF-β in proliferative vitreoretinal diseases and ROCK as a therapeutic target
Takeshi Kita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inhibition of activin receptor-like kinase 5 attenuates Bleomycin-induced pulmonary fibrosis
Hiroyuki Higashiyama et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2007)
The myofibroblast - One function, multiple origins
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-β2 in human retinal pigment epithelial cells
Yuji Itoh et al.
EXPERIMENTAL EYE RESEARCH (2007)
Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic sclerosis - A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
Christopher P. Denton et al.
ARTHRITIS AND RHEUMATISM (2007)
BMP1 controls TGFβ1 activation via cleavage of latent TGFβ-binding protein protein
Gaoxiang Ge et al.
JOURNAL OF CELL BIOLOGY (2006)
Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y-27632
Hiroto Yamaguchi et al.
JOURNAL OF BIOCHEMISTRY (2006)
Frequent alterations in the expression of serine/threonine kinases in human cancers
Maria Capra et al.
CANCER RESEARCH (2006)
Antisense oligonucleotides: From design to therapeutic application
JHP Chan et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)
The structure of dimeric ROCK I reveals the mechanism for ligand selectivity
M Jacobs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The Rho kinases I and II regulate different aspects of myosin II activity
A Yoneda et al.
JOURNAL OF CELL BIOLOGY (2005)
Apoptosis and oncosis in acute coronary syndromes: Assessment and implications
BI Jugdutt et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-β-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo
SK Kamaraju et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Parallel coiled-coil association of the RhoA-binding domain in Rho-kinase
T Shimizu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFP/ALK5 signaling
MJ Goumans et al.
MOLECULAR CELL (2003)
Evolution of protein kinase signaling from yeast to man
G Manning et al.
TRENDS IN BIOCHEMICAL SCIENCES (2002)
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice
FN Ziyadeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
